Titan Pharmaceuticals
Stock Forecast, Prediction & Price Target

Titan Pharmaceuticals Financial Estimates

Titan Pharmaceuticals Revenue Estimates

Titan Pharmaceuticals EBITDA Estimates

Titan Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$1.52M
 
N/A
$60K
 
-96.06%
$184K
 
206.66%
Avg: $7.05M
Low: $7.05M
High: $7.05M
avg. 3732.06%
Avg: $35.35M
Low: $35.35M
High: $35.35M
avg. 401.38%
Net Income
 
% change YoY
$-8.11M
 
N/A
$-10.17M
 
-25.42%
$-5.56M
 
45.27%
Avg: $-6.46M
Low: $-6.46M
High: $-6.46M
avg. -16.12%
Avg: $13.08M
Low: $13.08M
High: $13.08M
avg. 302.32%
EBITDA
 
% change YoY
$-9.79M
 
N/A
$-10.03M
 
-2.50%
$-7.16M
 
28.62%
Avg: $-7.05M
Low: $-7.05M
High: $-7.05M
avg. 1.59%
Avg: $-35.35M
Low: $-35.35M
High: $-35.35M
avg. -401.38%
EPS
 
% change YoY
-$16.68
 
N/A
-$15.15
 
9.17%
-$7.41
 
51.08%
Avg: -$8.6
Low: -$8.6
High: -$8.6
avg. -16.05%
Avg: $17.4
Low: $17.4
High: $17.4
avg. 302.32%
Operating Expenses
 
% change YoY
$10.68M
 
N/A
$10.29M
 
-3.61%
$7.46M
 
-27.52%
Avg: $194.43M
Low: $194.43M
High: $194.43M
avg. 2506.08%
Avg: $974.90M
Low: $974.90M
High: $974.90M
avg. 401.38%

FAQ

What is Titan Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 143.09% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -6.46M, average is -6.46M and high is -6.46M.

What is Titan Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 2066.72% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $7.05M, average is $7.05M and high is $7.05M.

What is Titan Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 143.13% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$8.6, average is -$8.6 and high is $-8.6.